COPD Flashcards
COPD Classification
GOLD 1 Mild FEV1 ≥ 80% predicted
GOLD 2 Moderate 50% ≤ FEV1 < 80% predicted
GOLD 3 Severe 30% ≤ FEV1 < 50% predicted
GOLD 4 Very Severe FEV1 < 30% predicted
COPD
Risk Factors
Smoking (#1)
Occupational dust
Chemical exposure
COPD
AECOPD Trigger
Viral URTI
Pneumonia
Environmental allergens or pollutants,
Smoking
CHF
PE
MI ≥ 80% predicted
COPD
Assessment
Cardinal Symptoms
↑ SOB, ↑ sputum production, ↑ sputum purulence
COPD
Assessment
Key Elements on History
Duration of symptoms
Severity of airflow limitation
Number of previous episodes (total/hospitalizations)
Co-morbidities
Premorbid functional status
Present treatment regimen
Previous use of mechanical
ventilation
Use of home oxygen
COPD
Assessment
Clinical Signs of Severity
Rapid shallow pursed-lip breathing
Use of accessory muscles
Paradoxical chest wall movements
Worsening or new onset central
cyanosis
Peripheral edema
Hemodynamic instability
Decreased LOC or confusion
Decreased O2 sat.
Consider PE if deteriorating & not improving with standard COPD therapy
COPD
investigations
Labs
CBC
CMP
VBG
Lactate
Respiratory Viral Panel
COPD
Investigations
Tests
CXR
ECG
Pulse oximetry
COPD
Management
Oxygen
Venturi masks (high-flow devices) preferred over nasal prongs
Target SaO2: >88% Goal PaO2 = 60-65mmHg
COPD
Management
Bronchodilators
SABA: Salbutamol 2.5-5mg via nebulizer or 4-8 puffs via MDI with spacer
q15mins x3 PRN
Anticholinergic: Ipratropium bromide 500μg via nebulizer or 4-8 puffs
q15mins x3 PRN
COPD
Management
Systemic Corticosteroids
Oral is equivalent to IV in most exacerbations
Oral Prednisone 40-60mg for 5-10 days
IV Methylprednisolone 125 mg BID-QID (for severe exacerbations or not
responding to oral steroids)
COPD
Management
Antibiotics
Indication: ≥2 of:
1) ↑ sputum production
2) ↑ sputum purulence
3) ↑ SOB
Simple exacerbation:
Amoxicillin
2nd/3rd gen Cephalosporin
Macrolide
Doxycycline or TMP/SMX
Complicated exacerbation: Fluoroquinolone or Amoxicillin/Clavulanate
COPD
Management
Ventilation
NIPPV such as CPAP or BiPAP (in respiratory acidosis severe dyspnea/distress
COPD
Management
Intubation
For life-threatening exacerbations
Failed NIPPV
Altered LOC
Severe hypoxemia
Cardiovascular instability
Respiratory or cardiac arrest